---
title: "InventisBio: Net loss of 61.8135 million yuan in the third quarter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263251686.md"
description: "InventisBio announced that its revenue for the third quarter was 11.7296 million yuan, a year-on-year increase of 173.86%; the net profit loss was 61.8135 million yuan. Revenue for the first three quarters was 30.8935 million yuan, a year-on-year increase of 61.27%; the net profit loss was 181 million yuan"
datetime: "2025-10-29T09:30:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263251686.md)
  - [en](https://longbridge.com/en/news/263251686.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263251686.md)
---

# InventisBio: Net loss of 61.8135 million yuan in the third quarter

InventisBio announced that its revenue for the third quarter was 11.7296 million yuan, a year-on-year increase of 173.86%; the net profit loss was 61.8135 million yuan. Revenue for the first three quarters was 30.8935 million yuan, a year-on-year increase of 61.27%; the net profit loss was 181 million yuan

### Related Stocks

- [688382.CN](https://longbridge.com/en/quote/688382.CN.md)

## Related News & Research

- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [Iran foreign ministry spokesperson says “We have received US views and are reviewing them”, Nour News reports](https://longbridge.com/en/news/287148443.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)